News

The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and ...
Alzheimer’s researcher Donald Weaver tells The Conversation Weekly podcast what he’s learnt during more than 30 years of ...
The FDA approved a test that can help clinicians diagnose Alzheimer's disease early on using a simple blood draw. The test ...
The father of the dominant theory of Alzheimer’s disease told another eminent researcher he is “causing harm” by criticizing his theory ...
A new study reveals how Alzheimer’s disease affects different tissues across the entire body — including biological aging, ...
The Herpes simplex virus hides in plain sight. For most, it’s a fleeting nuisance — a tingling lip, a blister, a cold sore.
Alzheimer’s is a complex disease caused by many interacting factors. It’s possible the herpes virus could play a small role – ...
The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.
The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase ...
Discover the surprising whole-body effects of Alzheimer's disease as evidence uncovers how brain proteins damage metabolism, ...
Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...
The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...